5-fluoro-1,3-dihydroindol-2-one

5-Fluoro-1,3-dihydroindol-2-one is a research compound belonging to the class of VEGFR-2 (kinase insert domain receptor) inhibitors. These synthetic molecules bind competitively to the ATP site of the tyrosine kinase domain, potentially interfering with signaling pathways involved in tumor proliferation, metastasis, and angiogenesis.